Articles

  • Jun 13, 2024 | wsj.com | Jessica Mendoza |Matt Kwong |Peter Loftus

    In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly LLY -0.62%decrease; red down pointing triangle, was on a West Coast college tour with his daughter when his phone rang. A deputy was calling with good news: The company’s new, experimental drug tirzepatide not only cut blood-sugar levels in people with diabetes in a small clinical trial, it also helped them lose much more weight than prior weight-loss drugs could achieve.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
3K
Tweets
9K
DMs Open
Yes
Matt Kwong
Matt Kwong @matt_kwong
15 May 25

Our series Trillion Dollar Shot is an #NIHCMAwards finalist! What a privilege to have made it with this delightful crew https://t.co/fbMJiSszkc

NIHCM
NIHCM @NIHCMfoundation

Congratulations to the Television and Audio finalists for the 31st Annual #NIHCMAwards in Journalism! We are delighted to recognize their outstanding work. Read the webpage for more: https://t.co/MZQGXYHLXG https://t.co/JLtWjxjezW

Matt Kwong
Matt Kwong @matt_kwong
4 Feb 25

RT @Ryan_Knutson: 100 million streams on Spotify!! Way to go everyone! @kate_linebaugh @_jessicamendoza @parahslatt @ardzes @annieminoff @B…

Matt Kwong
Matt Kwong @matt_kwong
3 Feb 25

RT @JustinTrudeau: I just had a good call with President Trump. Canada is implementing our $1.3 billion border plan — reinforcing the borde…